- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06032299
Dual Implant Versus Single Implant Distal End of Femur
May 8, 2024 updated by: Brandon James Yuan, Mayo Clinic
Pilot for Dual Implant Versus Single Implant Distal End of Femur (pDISIDE Femur)
This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Femur fracture distal to the femoral diaphysis.
- Operative treatment within 72 hours of presenting to the treating hospital.
- Patient was previously ambulatory.
- Fracture amendable to either single or dual implant fixation.
- Informed consent can be obtained from the patient, family member, or power of attorney.
Exclusion Criteria:
- Associated major lower extremity fracture.
- Ongoing infection.
- History of metabolic bone disease (Paget's, etc).
- Pathologic fracture.
- Open fracture.
- Severe cognitive impairment (Six Item Screener with 3 or more errors).
- Stage 5 Parkinson's disease.
- Significant femoral bone loss requiring planned staged bone grafting.
- Vascular injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Single Distal Femur Implant Group
Subjects will receive one of two types of implants for the distal femur fracture.
The single implant will be either a plate and screws or a rod.
The type of single implant used will be determined by the surgeon based on the characteristics of the fracture.
|
Single implant constructs will be either a retrograde intramedullary nail with interlocking screws or a single plate and screw construct.
|
Experimental: Dual Distal Femur Implant Group
Subjects will receive two implants for fixation of the distal femur fracture.
The dual implant will be either 2 plates with screws or a plate with screws and a rod.
The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.
|
Dual implant constructs will either be an intramedullary nail with an additional plate and screw construct or dual (two plates in any orientation) plate and screw construct.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of study-eligible subjects
Time Frame: Baseline
|
Total number of subjects to be enrolled in the study
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operative times
Time Frame: Duration of surgery, approximately 2-4 hours
|
Total recorded amount of time in minutes to complete the surgery
|
Duration of surgery, approximately 2-4 hours
|
Blood loss
Time Frame: Duration of surgery, approximately 2-4 hours
|
Total amount of surgical blood loss, reported in mL.
|
Duration of surgery, approximately 2-4 hours
|
Hospitalization days
Time Frame: approximately 2-3 days
|
Total number of days a subject requires hospitalization after surgery
|
approximately 2-3 days
|
Early post-surgical complications
Time Frame: 2 weeks post-surgery
|
Number of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery
|
2 weeks post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brandon Yuan, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
September 1, 2025
Study Completion (Estimated)
September 1, 2025
Study Registration Dates
First Submitted
September 2, 2023
First Submitted That Met QC Criteria
September 2, 2023
First Posted (Actual)
September 11, 2023
Study Record Updates
Last Update Posted (Actual)
May 10, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-004415
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femur Fracture
-
Orthofix s.r.l.RecruitingPertrochanteric Fracture of Femur | Intertrochanteric Fracture of Femur | Subtrochanteric Fracture of FemurItaly
-
University of FloridaRecruitingDistal Femur FractureUnited States
-
AO Clinical Investigation and Publishing DocumentationActive, not recruitingDistal Femur FractureUnited States, Switzerland
-
Nationwide Children's HospitalTerminated
-
Ilocos Training and Regional Medical CenterUnknownIntertrochanteric Fractures | Pertrochanteric Fracture | Pertrochanteric Fracture of Femur, Closed | Pertrochanteric Fracture of Femur, Open
-
University of Alabama at BirminghamCompletedSupracondylar Femur FractureUnited States
-
Hadassah Medical OrganizationUnknownProximal Femur FractureIsrael
-
Amr Gamaleldin Mahmoud Khalil GendyaCompletedGeriatrics | Distal Femur FractureEgypt
-
University Health Network, TorontoRecruiting
-
Children's Hospital Los AngelesPediatric Orthopaedic Society of North AmericaActive, not recruiting
Clinical Trials on Single Distal Femur Implant
-
University of UtahEnrolling by invitation
-
AO Clinical Investigation and Publishing DocumentationActive, not recruitingDistal Femur FractureUnited States, Switzerland
-
Unity Health TorontoRecruitingKnee Fracture | Distal Femur Fracture | Periprosthetic Fracture Around Prosthetic Joint Implant KneeCanada
-
University of FloridaRecruitingDistal Femur FractureUnited States
-
Nova Scotia Health AuthorityAO Research Fund; Synthes CanadaCompleted
-
Chang Gung Memorial HospitalCompleted
-
University Hospital, BrestCompleted
-
October University for Modern Sciences and ArtsCompleted
-
Alexandria UniversityCompletedAlveolar Bone LossEgypt
-
Stanford UniversityRecruitingPancreatic Neoplasms | Biliary Tract Neoplasms | Choledocholithiasis | Biliary Disease | Pancreatic Disease | Biliary ObstructionUnited States